AMENDMENT N0.1 TO FORM 20-F
 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 20-F/A

(Amendment No. 1)

     
o
  REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE
SECURITIES EXCHANGE ACT OF 1934
 
    
  Or
 
    
þ
  ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
  For the fiscal year ended March 31, 2004
 
    
  Or
 
    
o
  TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
  For the transition period from                     to                    

Commission File Number: 1-15182

DR. REDDY’S LABORATORIES LIMITED

(Exact name of Registrant as specified in its charter)
     
Not Applicable   ANDHRA PRADESH, INDIA
(Translation of Registrant’s name   (Jurisdiction of incorporation or
into English)   organization)

7-1-27, Ameerpet
Hyderabad, Andhra Pradesh 500 016, India
+91-40-23731946
(Address of principal executive offices)

Securities registered or to be registered pursuant to Section 12(b) of the Act:

     
Title of Each Class
   Name of Each Exchange on which Registered
American depositary shares, each representing one equity share
  New York Stock Exchange
 
   
Equity Shares*
  New York Stock Exchange

*Not for trading, but only in connection with the registration of American depositary shares, pursuant to the requirements of the Securities and Exchange Commission.

Securities registered pursuant to Section 12(g) of the Act: None

Securities for which there is a reporting obligation pursuant to Section 15(d) of the Act: None

Indicate the number of each of the issuer’s classes of capital or common stock as of the close of the period covered by the annual report.

76,518,949 Equity Shares

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes þ No o

Indicate by check mark which financial statement item the registrant has elected to follow.

Item 17 o Item 18 þ

 

 

EXPLANATORY NOTE

The purpose of this amendment to our Annual Report on Form 20-F is solely to amend the exhibits listed in Item 19 to include a letter of consent from KMPG LLP. This amendment to our Annual Report on Form 20-F does not otherwise update the information set forth in the original filing of the Annual Report on Form 20-F.

 

 

Item 19. Exhibits

     
Exhibit Number
   Description of Exhibits
1.1.*/***
  Memorandum and Articles of Association of the Registrant dated February 4, 1984.
1.2.*/***
  Certificate of Incorporation of the Registrant dated February 24, 1984.
1.3.*/***
  Amended Certificate of Incorporation of the Registrant dated December 6, 1985.
2.1.*
  Form of Deposit Agreement, including the form of American Depositary Receipt, among Registrant, Morgan Guaranty Trust Company as Depositary, and holders from time to time of American Depositary Receipts Issued there under, including the form of American Depositary.
4.1.*
  Agreement by and between Dr. Reddy’s Laboratories Limited and Dr. Reddy’s Research Foundation regarding the undertaking of research dated February 27, 1997.
4.2.**
  Dr. Reddy’s Laboratories Limited Employee Stock Option Scheme, 2002.
8.****
  List of subsidiaries of the Registrant.
23.1
  Consent of KPMG LLP (independent accountants).
99.1****
  Certification of Chief Executive Officer, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
99.2****
  Certification of Chief Financial Officer, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
99.3****
  Certification of Chief Executive Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
99.4****
  Certification of Chief Financial Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

*   Previously filed on March 26, 2001 with the SEC along with Form F-1
 
**   Previously filed with the Company’s Form 20-F for the year ended March 31, 2002
 
***   Previously filed with the Company’s Form 20-F for the year ended March 31, 2003
 
****   Previously filed with the Company’s Form 20-F for the year ended March 31, 2003

 

 

SIGNATURES

The registrant hereby certifies that it meets all of the requirements for filing on Form 20–F/A and that it has duly caused and authorized the undersigned to sign this Amendment No. 1 to Annual Report on its behalf

         
  DR. REDDY’S LABORATORIES LIMITED
 		  
  By:   /s/ G.V. Prasad    
    G.V. Prasad   
    Executive Vice Chairman & CEO   
 
     
  By:   /s/ V.S. Vasudevan    
    V.S. Vasudevan   
    Chief Financial Officer   
 

 

 

EXHIBIT INDEX

     
Exhibit Number
   Description of Exhibits
1.1.*/***
  Memorandum and Articles of Association of the Registrant dated February 4, 1984.
1.2.*/***
  Certificate of Incorporation of the Registrant dated February 24, 1984.
1.3.*/***
  Amended Certificate of Incorporation of the Registrant dated December 6, 1985.
2.1.*
  Form of Deposit Agreement, including the form of American Depositary Receipt, among Registrant, Morgan Guaranty Trust Company as Depositary, and holders from time to time of American Depositary Receipts Issued there under, including the form of American Depositary.
4.1.*
  Agreement by and between Dr. Reddy’s Laboratories Limited and Dr. Reddy’s Research Foundation regarding the undertaking of research dated February 27, 1997.
4.2.**
  Dr. Reddy’s Laboratories Limited Employee Stock Option Scheme, 2002.
8.****
  List of subsidiaries of the Registrant.
23.1
  Consent of KPMG LLP (independent accountants).
99.1****
  Certification of Chief Executive Officer, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
99.2****
  Certification of Chief Financial Officer, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
99.3****
  Certification of Chief Executive Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
99.4****
  Certification of Chief Financial Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

*   Previously filed on March 26, 2001 with the SEC along with Form F-1
 
**   Previously filed with the Company’s Form 20-F for the year ended March 31, 2002
 
***   Previously filed with the Company’s Form 20-F for the year ended March 31, 2003
 
****   Previously filed with the Company’s Form 20-F for the year ended March 31, 2003